Skip to main content
Kosj Yamoah, MD, Radiation Oncology, Tampa, FL

KosjKosjYamoahMDPhD

Radiation Oncology Tampa, FL

Chairman, Department of Radiation Oncology

Overview of Dr. Yamoah

Dr. Kosj Yamoah is a radiation oncologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. He received his medical degree from Icahn School of Medicine at Mount Sinai and has been in practice 12 years. He is one of 64 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Radiation Oncology. He has more than 100 publications and over 500 citings.

Education & Training

  • Sidney Kimmel Medical College at Thomas Jefferson University/TJUH
    Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Radiation Oncology, 2011 - 2015
  • Atlantic Health System
    Atlantic Health SystemInternship, Transitional Year, 2010 - 2011
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiClass of 2010

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2015 - 2025
  • PA State Medical License
    PA State Medical License 2011 - 2015
  • MO State Medical License
    MO State Medical License 2013 - 2014
  • American Board of Radiology Radiation Oncology

Clinical Trials

Publications & Presentations

PubMed

Authored Content

  • Who Needs Early Salvage RT and Who Needs Adjuvant RT in 2022? With Dr Kosj YamoahAugust 2022
  • Who Needs Early Salvage Radiotherapy and Who Needs Adjuvant Radiotherapy in 2022? - Kosj YamoahJuly 2022

Press Mentions

  • Veracyte’s RNA Genetic Test Predicts Black Men’s Aggressive Prostate Cancer
    Veracyte’s RNA Genetic Test Predicts Black Men’s Aggressive Prostate CancerOctober 3rd, 2024
  • New Data Presented at ASTRO 2024 Show That Veracyte’s Decipher Prostate Test Predicts Aggressive Prostate Cancer in African American Men
    New Data Presented at ASTRO 2024 Show That Veracyte’s Decipher Prostate Test Predicts Aggressive Prostate Cancer in African American MenOctober 2nd, 2024
  • Genomic Testing Can Identify African American Prostate Cancer Patients Who Have High-Risk Disease
    Genomic Testing Can Identify African American Prostate Cancer Patients Who Have High-Risk DiseaseSeptember 23rd, 2022
  • Join now to see all

Professional Memberships